Using CAR-T Therapy Strategically in Myeloma Care | Charlotte Roundtable, May 4th, 2024

  Рет қаралды 477

HealthTree Foundation for Multiple Myeloma

HealthTree Foundation for Multiple Myeloma

Күн бұрын

Пікірлер
Bispecific Antibody Therapy in Multiple Myeloma | Charlotte Roundtable, May 4th, 2024
30:31
HealthTree Foundation for Multiple Myeloma
Рет қаралды 463
Newly Diagnosed Myeloma Care | Charlotte Roundtable, May 4th, 2024
30:40
HealthTree Foundation for Multiple Myeloma
Рет қаралды 362
Sigma Kid Mistake #funny #sigma
00:17
CRAZY GREAPA
Рет қаралды 30 МЛН
CAR T-Cells and Safety Signals
25:26
NEJM Group
Рет қаралды 835
CAR T-cell Therapy: The Good, The Bad and The Long-Term 2022
59:12
CAR-T  Cell Therapy: Current Uses and Future Possibilities
58:59
Mayo Clinic
Рет қаралды 4,4 М.
Latest Myeloma Updates from ASH 2024: Easy-to-Understand Insights for Patients and Care Partners
1:36:31
The Role of Maintenance Therapy in Today's Myeloma: Has Anything Changed?
1:04:44
HealthTree Foundation for Multiple Myeloma
Рет қаралды 1,6 М.
Bispecific Antibodies | High Impact Topic (HIT)
6:09
Multiple Myeloma Research Foundation - MMRF
Рет қаралды 2,4 М.
CAR T Cell Therapy for Autoimmune Disease
5:17
GlomCon Foundation
Рет қаралды 2,8 М.
Real-World CAR-T Data Update
55:08
HealthTree Foundation for Multiple Myeloma
Рет қаралды 1,3 М.
Immunotherapy 101 for Multiple Myeloma Patients
56:40
HealthTree Foundation for Multiple Myeloma
Рет қаралды 1,4 М.
High-risk Vs Standard-Risk Relapsed/Refractory Myeloma | Charlotte Roundtable, May 4th, 2024
39:28
HealthTree Foundation for Multiple Myeloma
Рет қаралды 611